Suppr超能文献

费加罗树(铁青树科)茎皮水提物对谷氨酸单钠诱导肥胖相关心血管风险的影响:体内和体外评价。

Effects of stem bark aqueous extract of Fagara tessmannii Engl (Rutaceae) on cardiovascular risks related to monosodium glutamate-induced obesity in rat: In vivo and in vitro assessments.

机构信息

Department of Animal Biology and Physiology, Laboratory of Animal Physiology, University of Yaoundé I, P.O. Box 812, Yaoundé, Cameroon.

Department of Biological Sciences, Higher Teachers' Training College, University of Yaoundé I, P.O. Box 47, Yaoundé, Cameroon.

出版信息

J Ethnopharmacol. 2020 Oct 5;260:112972. doi: 10.1016/j.jep.2020.112972. Epub 2020 May 22.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Fagara tessmannii is a shrub of the African rainforests in South-West, Centre, South and East provinces in Cameroon. It is used in traditional medicine for the treatment of tumors, swellings, inflammation, gonorrhoea, schistosomiasis, antifungal, heart diseases and as anti-hypertensive.

AIM OF THE STUDY

We investigated the potential effects of F. tessmannii on cardiovascular risk related to monosodium glutamate-induced obesity.

MATERIALS AND METHODS

Monosodium glutamate (MSG, 4 mg/g/day) was injected subcutaneously to newborn Wistar rats for the four consecutive first days of their life and on the 6th, 8th and 10th day after birth. After 21 weeks, obese rats were treated orally with F. tessmannii (100 or 200 mg/kg/day), orlistat (10 mg/kg/day) or telmisartan (10 mg/kg/day) for 6 weeks. Body weight, obesity, body mass index (BMI), Lee index, insulin sensitivity and glucose tolerance, blood pressure, lipid profile as a Coronary Risk Index (CRI), and reactivity of isolated thoracic aorta were evaluated.

RESULTS

In addition to significantly decrease body weight (17.60% and 20.34%), BMI, Lee's index, retroperitoneal fat, total adiposity, and coronary risk indicators, F. tessmannii has significantly decreased insulin resistance and hyperglycemia and high blood pressure observed in MSG-obese rats. The high contractility to phenylephrine as well as the hypersensitivity to sodium nitroprusside (a nitric oxide-donor), observed in MSG aortic rings were significantly reduced by the F. tessmannii extract. Enhanced serum Na and Cl levels and decreased K observed in obese rats were also significantly reversed after F. tessmannii treatment.

CONCLUSIONS

F. tessmannii fights against obesity and associated cardiovascular risks by modulating production and vascular responsiveness to vasoactive factors, monitoring premature aging. F. tessmannii promotes the loss of ectopic fat and other fatty tissues, the sensitivity of the peripherical tissues to insulin, the energy expenditure and the renovascular decompression and regulates ions movement which prevents hypertension.

摘要

民族药理学相关性

Fagara tessmannii 是一种生长于非洲雨林的灌木,分布于喀麦隆西南部、中心部、南部和东部省份。在传统医学中,它被用于治疗肿瘤、肿块、炎症、淋病、血吸虫病、抗真菌、心脏病和高血压。

研究目的

我们研究了 F. tessmannii 对谷氨酸单钠诱导肥胖相关心血管风险的潜在影响。

材料和方法

在新生 Wistar 大鼠生命的前 4 天每天皮下注射谷氨酸单钠(MSG,4mg/g),然后在出生后的第 6、8 和 10 天再注射。21 周后,肥胖大鼠连续 6 周口服 F. tessmannii(100 或 200mg/kg/天)、奥利司他(10mg/kg/天)或替米沙坦(10mg/kg/天)。评估体重、肥胖、体重指数(BMI)、李指数、胰岛素敏感性和葡萄糖耐量、血压、血脂谱作为冠心病风险指数(CRI),以及离体胸主动脉的反应性。

结果

除了显著降低体重(17.60%和 20.34%)、BMI、李指数、腹膜后脂肪、总脂肪和冠心病风险指标外,F. tessmannii 还显著降低了 MSG 肥胖大鼠的胰岛素抵抗和高血糖及高血压。F. tessmannii 提取物显著降低了 MSG 主动脉环对苯肾上腺素的高收缩性和对硝普钠(一氧化氮供体)的超敏性。肥胖大鼠中增强的血清 Na 和 Cl 水平和降低的 K 水平在 F. tessmannii 治疗后也得到显著逆转。

结论

F. tessmannii 通过调节血管活性因子的产生和血管反应性来对抗肥胖及其相关的心血管风险,监测过早衰老。F. tessmannii 促进异位脂肪和其他脂肪组织的丢失、外周组织对胰岛素的敏感性、能量消耗和肾血管减压,并调节离子运动,从而预防高血压。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验